NDC 61958-1901 – Genvoya
Elvitegravir 150 mg/1; Cobicistat 150 mg/1; Emtricitabine 200 mg/1; Tenofovir Alafenamide Fumarate 10 mg/1 · Tablet · Oral
Product NDC61958-1901
Product details
- Brand name
- Genvoya
- Generic name
- elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA207561
- Marketed since
- November 5, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cytochrome P450 3A Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Elvitegravir 150 mg/1
- Cobicistat 150 mg/1
- Emtricitabine 200 mg/1
- Tenofovir Alafenamide Fumarate 10 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-1901-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-1901-1) | Nov 5, 2015 |